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1. Introduction  
Oligodendrocytes (OL) are cells of the glial lineage which play a critical role in the central 
nervous system (CNS) by producing the multilamellar protein, myelin. Oligodendrocytes 
extend processes which wrap around the axons of several neurons. This myelin sheath 
increases neuronal conduction by decreasing ion leakage and capacitance of the axonal 
membrane and increasing saltatory conduction. Damage to oligodendrocytes results in loss 
of myelin and consequent functional impairment due to loss or decay of neuronal 
conduction. Demyelination in the CNS is the hallmark of conditions such as spinal cord 
injury (SCI), transverse myelitis and multiple sclerosis – resulting in functional impairment 
across the sensory, motor and cognitive domains. Current research on treatment of SCI 
focuses on the implantation of oligodendrocyte progenitor cells (OPC) into the injured 
region to achieve remyelination of the spared axons and potentially repair the sensory and 
motor pathways. However, this approach requires a large and relatively pure population of 
OPCs, which are differentiated from other multipotent cell lineages. Human embryonic 
stem cells have been used in several studies for this purpose and hence, it is important to 
understand the molecular mechanisms regulating the differentiation of pluripotent hESCs to 
oligodendrocytes. Elucidation of such mechanisms may lead to the development of more 
efficient differentiation protocols and the derivation of cells with improved myelination 
potential for implantation in injured spinal cords.  
While the molecular basis for hESC differentiation into OL lineage cells is not completely 
understood, several recent studies have filled some of the gaps in our knowledge of the 
field. The journey from a pluripotent state to commitment to the OL fate is characterized by 
a complex interplay between genetic regulation and epigenetic modifiers such as histone 
modification, DNA methylation and microRNAs (miRNAs). Global miRNA expression 
profiling of OL differentiation from hESCs has revealed that a significant number of the 
differentially expressed miRNAs have targets hypothesized to be involved in myelination 
and OL development. Such studies are complemented by histone modification analyses in 
ESCs which show that specific histone acetyltransferases (HATs) and histone deacetylases 
(HDACs) are up- or down-regulated during different time points in OL differentiation to 
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guide myelin production. This review focuses on the role of miRNAs in oligodendrocyte 
development from human embryonic stem cells and elucidates a new protocol developed to 
obtain oligodendrocytes from human embryonic stem cells with high yield and purity. 
2. MicroRNA regulation of oligodendrocyte development 
To date, many studies have attempted to unravel mechanisms of stem cell fate 
determination by studying gene expression by measuring messenger RNA (mRNA) 
expression. However, in the early-mid 90’s a novel class of RNA molecules was discovered 
that regulated gene expression at the level of translation in C. elegans. These RNAs were 
shown to regulate the translation of a target mRNA, by directly base-pairing to its 3'-
untranslated region (3' UTR) (Lee, Feinbaum & Ambros 1993, Wightman, Ha & Ruvkun 
1993). Nevertheless, the broad significance of these small RNAs was not fully appreciated 
until only a few years ago when many similar molecules were further identified in C. 
elegans, Drosophila, and in some mammals (Lee, Ambros 2001, Lagos-Quintana et al. 2001), 
and these newly recognized regulatory RNAs were termed microRNAs (miRNAs or miRs). 
To date, sequencing libraries of cloned small RNAs and bioinformatic analyses of genomic 
sequences have led to the identification of ~500 verified mammalian miRNAs while studies 
exploiting the high degree of conservation of miRNAs across mammalian genomes have 
suggested that as many as 1000 human miRNAs are likely to exist (Berezikov et al. 2005, 
Bentwich et al. 2005). Despite these great advances in the identification of miRNAs, our 
understanding of their roles in cellular processes remains at a very early stage although 
there is evidence suggesting that miRNA dysfunction contributes significantly to 
oncogenesis and stem cell self-renewal. 
MiRNAs are found in plants, viruses and animals and are generated via a multi-stage 
process. In mammals they are first transcribed as long precursor transcripts (~60-80 
nucleotides) known as primary (pri)-miRNAs containing a hairpin loop (Lee et al. 2002). Pri-
miRNAs are then processed into shorter hairpin shaped precursors (pre)-miRNAs in the 
nucleus and transported to the cytoplasm. There, the RNase-III enzyme Dicer performs a 
second cleavage to generate a double-stranded 21-23 nucleotide RNA molecule (Bernstein et 
al. 2001, Grishok et al. 2001, Hutvágner et al. 2001, Ketting et al. 2001, Knight, and Bass 
2001). A large protein complex known as the RNA-induced silencing complex, or RISC, 
associates with this RNA duplex and unwinds it. Generally, only one strand is stably 
incorporated into RISC while the other is discarded and rapidly degraded (Meister et al. 
2004). After the RISC is formed the miRNAs guide it to the target mRNA that is 
subsequently cleaved or translationally silenced. The degree of complementarity between a 
miRNA and its target dictates the mechanism of silencing (Meister et al. 2004, Hutvágner et 
al. 2004, Brennecke et al. 2003) 
While degradation occurs predominantly in plants, in mammals the predominant 
mechanism appears to be through imperfect base-pairing between a miRNA and its target, 
resulting in translational silencing through a complex mechanism that appears to involve 
inhibition of both translation initiation and elongation (Pillai, Bhattacharyya & Filipowicz 
2007).  
MiRNAs are attractive candidates for regulating stem cell identity, which includes self-
renewal and cell fate decisions, as their ability to simultaneously regulate many targets 
provides a means for coordinated control of gene action (Chen et al. 2007). Although direct 
functional roles in stem cell biology are just emerging, corroborating evidence from 
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expression patterns, predicted targets, and from overexpression studies suggests miRNAs 
are key regulators (Cheng et al. 2005). For example, the loss of Dicer1 in mice has been 
demonstrated to cause embryonic lethality as well as loss of stem cell populations 
implicating a role for miRNAs in stem cell self-renewal (Bernstein et al. 2003, Murchison et 
al. 2005). Based on several reports from mouse and human studies, distinct sets of miRNAs 
are expressed specifically in pluripotent stem cells and not in adult tissues further 
implicating their role in stem cell self-renewal. In addition, Argonaute family proteins, 
which are key components of the RISC complex, have also been shown to be required in the 
maintenance of germline stem cells in different organisms (Carmell et al. 2002). 
The role of miRNAs in oligodendrocyte fate determination has been a recent field of 
research and a few studies have reviewed the state of the current knowledge on the subject 
(He et al. 2011, Emery 2010, Dugas, Notterpek 2011).. This chapter aims to review the 
advances made in understanding oligodendrocyte fate determination by miRNAs and 
elucidate a novel protocol to derive OLs from embryonic stem cells in vitro to study their 
development.  
2.1 MicroRNAs in glial fate determination 
Zheng et al first reported that miRNAs were essential for the “developmental switch from 
neurogenesis to gliogenesis” (Zheng et al. 2010). The authors deleted Dicer, a protein 
necessary for functional miRNA synthesis, in the mouse ventral spinal neuroepithelium, 
where embryonic gliogenesis occurs. Neural patterning and motor neuron development 
occurred even in the absence of miRNA formation, showing that they are probably not 
involved in neuron maturation. However, oligodendrogenesis in the ventral spinal cord was 
blocked in the absence of Dicer, as confirmed by the complete absence of PDGFRǂ+ cells 
and a huge reduction in Sox10+ cells in the spinal cord parenchyma of Dicer mutants. On 
similar lines, astrogliogenesis was also found to be miRNA-dependent, as the study found 
that Dicer deletion led to the complete block of the development of a subset of astrocytes 
from the ventral neuroepithelium. This was confirmed by the lack of GFAP immunostaining 
of a small region flanking the floor plate when compared to the control. However, this study 
did not implicate any specific miRNA species as being involved in the regulation of 
gliogenesis in the developing spinal cord.  
2.2 MicroRNAs in oligodendrocyte development 
A 2009 study by Shin et al definitively established that miRNAs were involved in epigenetic 
regulation of oligodendrocyte function. This was performed by the OL-specific knockout of 
Dicer in postnatal mice. The Dicer protein is essential for synthesis of functional miRNAs 
and it was found that its elimination in postnatal OLs led to demyelination, oxidative 
damage, inflammatory astrocytosis and microgliosis in the brain. This phenotype resulted 
primarily from the disruption of miR-217 and consequent upregulation of its target ELOVL7 
(elongation of very long chain fatty acids protein 7). Overexpression of ELOVL7 leads to 
lipid accumulation in the myelin rich regions of the brain and significant decrease in 
peroxisomal ǃ-oxidation activity (Shin et al. 2009).  
In the first study to analyze the global miRNA expression pattern in oligodendrocytes, Lau 
et al identified 98 miRNAs expressed by developing oligodendrocytes in the postnatal rat 
brain and found that 37 of these have an mRNA bias (Lau et al. 2008). In addition, the 
predicted protein targets of 13 miRNAs were dynamically regulated during OL 
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development. In particular, the study identified miR-9 as a candidate miRNA with an 
important regulatory role during the transition from OPC (A2B5+/GalC−) to 
premyelinating OL (A2B5+/GalC+) and it was found that miR-9 downregulated the 
expression of the peripheral myelin protein (PMP) 22. PMP22 is expressed by Schwann cells 
and is a component of the compact myelin of the peripheral nervous system. Interestingly, 
miR-9 is not expressed by Schwann cells.  
Another study identified miR-23 and its target, Lamin B1 (LMNB1) as a regulatory 
component of OL differentiation (Lin, Fu 2009). Genomic duplication of LMNB1 has been 
implicated in autosomal dominant leukodystrophy (Padiath et al. 2006), a disease 
characterized by severe myelin loss in the CNS. Nuclear lamins such as LMNB1 interact 
with heterochromatin to regulate DNA synthesis and transcription and LMNB1 specifically 
regulates OL function; this was confirmed by the repression of transcription of OL-specific 
genes such as myelin basic protein (MBP), proteolipid protein (PLP) and myelin 
oligodendrocyte glycoprotein (MOG) by overexpression of LMNB1. The Lin et al study 
showed that miR-23 downregulates LMNB1 in normal OLs and that downregulation of 
LMNB1 by miR-23 was important for the development of OLs from glial cell cultures (Lin, 
Fu 2009). The effect of LMNB1 on differentiation was confirmed by the observation that 
increased LMNB1 gene dosage caused an arrest in differentiation and led to the 
development of an MBP and PLP negative phenotype. This was hypothesized to be due to 
either faulty transcription of these genes or defective nuclear export.  
A 2010 study by Zhao et al identified miR-219 and miR-338 as OL-specific miRNAs. This was 
confirmed by the complete absence of these two miRNAs in the spinal cord of Olig1 mutant 
mice. Fluorescent in situ hybridization revealed that miR-219 and miR-338 positive cells were 
found only in the white matter of the spinal cord, which is where OLs reside. Further, it was 
found that these two miRNAs promoted OPC maturation in vitro and in vivo. Transfection of 
OPC-enriched cultures with these miRNAs led to a significant increase in the number of MBP+ 
cells (a marker of mature OLs) and a slight decrease in the number of PDGFRǂ+ OPCs. MiR-
219 and miR-338 were also found to be necessary for OL maturation. The study also identified 
Sox6 and Hes5 as potential protein targets of these miRNAs. These two transcription factors 
are inhibitors of OL maturation and have been shown to downregulate myelin gene 
expression and oligodendrocyte maturation (Kondo, Raff 2000, Liu et al. 2006). Sox6 and Hes5 
are downregulated by miR-219 and miR-338. The authors suggest that commitment to the 
oligodendroglial lineage would require downregulation of transcription factors which induce 
differentiation to other neural cell fates and this was confirmed by the observation that miR-
219 and miR-338 also downregulated other proneurogenic transcription factors such as 
NeuroD1, Isl1 and Otx2. In summary, these two miRs promote OL maturation by 
simultaneously inhibiting the inhibitors of OL differentiation and transcription factors which 
promote differentiation to non-OL neural cell fates.  
Another recent study confirmed the importance of miR-219 and miR-338 in OL 
differentiation and maturation (Dugas et al. 2010). In addition, it also found miR-138 to be 
strongly upregulated during OL differentiation. Among the three, miR-219 was found to be 
the strongest inducer of OL differentiation and its transfection in a purified OPC population 
increased the number of differentiated OLs expressing both early (CNP, MBP) and late 
(MOG) OL markers. OLs induced by transfection with miR-138 only expressed early OL 
markers. As expected, OL-specific miRNAs were found to target genes that are repressed 
during OL differentiation. In addition, this study also found that miR-219 downregulates 
inhibitors of OL differentiation. The validated targets of miR-219 were found to include 
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PDGFRǂ, Sox6, FoxJ3 and ZFP238. PDGF has been known to be an OPC mitogen for 
multiple decades (Besnard et al. 1987). ZFP238 and FoxJ3 had previously not been 
functionally characterized in OPCs and this study confirmed that FoxJ3 and ZFP238 are 
inhibitors of OL differentiation by constitutively expressing these genes in OPCs and 
observing significantly reduced differentiation to the mature OL stage.  
A study by Letzen et al was the first to perform a global miRNA analysis of cells isolated 
from 8 developmental stages from the pluripotent embryonic stem cell state to a mature, 
myelinating OL state (Letzen et al. 2010). Significantly, this study analyzed the expression of 
miRNAs in human cells as opposed to rodent models used in prior investigations. The study 
detected 183 miRNAs over the eight stages of oligodendrocyte maturation and also 
identified the highest differentially expressed miRNAs at each transition in the pluripotent-
to-mature OL differentiation scheme. These differentially-expressed miRNAs were then 
matched to potential protein targets which revealed proteins such as chromosome 11 open 
reading frame 9 (C11orf9), claudin-11 (Cldn11), myelin transcription factor 1-like (Mytl1), 
myelin-associated oligodendrocyte basic protein (Mobp), myelin protein zero-like 2 
(Mpzl2), and discoidin domain receptor tyrosine kinase 1 (Ddr1). The study focused on two 
miRNAs – miR-199a-5p and miR145, both of which show a decreasing expression level 
during the early to mid OP transition. C11orf9, which appears to be the human analog of the 
mouse myelin regulatory factor (MRF) was the target protein predicted for these 2 miRNAs. 
MRF has been shown to be necessary for myelination and OL maturation (Emery et al. 
2009). It is thought that the decrease in miR199a-5p levels during OPC maturation may be 
parallel to the observed increase in MRF expression during the same time window, 
implying that miR-199a-5p may be one of the regulators of myelination and OPC 
maturation. MiR-214 was also observed to be strongly downregulated during the early-to-
mid OPC transition and its predicted target is myelin-associated oligodendrocyte basic 
protein (MOBP), an important structural component of myelin.  
2.3 Oligodendrocytes, miRNA and disease 
Dysfunctional oligodendrocytes due to misregulation by miRNAs have recently been 
implicated in diseases of the central nervous system. For instance, mutations in several 
miRNAs have been discovered in the pathogenesis of multiple sclerosis (MS) (Junker, 
Hohlfeld & Meinl 2010). Specifically, miR-219 and miR-338 showed the maximum relative 
reduction in expression when the entire microRNAome of healthy, mature OLs was 
compared with chronic, inactivated MS tissue lesions (Junker et al. 2009). Other reports have 
also shown that miRNAs provide a mechanism for resistance against viral infection, and 
that miR-122 levels were significantly reduced in OLs infected with the Borna disease virus. 
This is significant as the Borna disease virus causes neurological disease in animals, and 
recent findings have implicated that it may also play a role in some human neurological and 
psychiatric conditions including bipolar disorder and depression (VandeWoude et al. 1990). 
In this case, overexpression of miR-122 inhibited viral protein synthesis and viral gene 
transcription and translation (Qian et al. 2010).  
In one study to examine the possible role of miRNAs in the development of schizophrenia, 
the expression levels of 435 miRNAs in postmortem brain samples of schizophrenic patients 
were compared with those of psychiatric healthy controls (Moreau et al. 2011). In this study, 
19% of the miRNAs analyzed showed misexpression in the schizophrenic samples, with 
these miRNAs mostly being downregulated compared to the healthy controls. On the other 
hand, a previous study identified differential expression of 28 miRNAs in the postmortem 
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dorsolateral prefrontal cortex (Brodmanns Area) of schizophrenic individuals (Santarelli et 
al. 2011). 89% of these 28 miRNAs were upregulated and quantitative PCR was used to 
validate this finding for miR-328, miR-17-5p, miR-134, miR-652, miR-382, and miR-107. This 
elevation was linked to the observed upregulation of Dicer activity in these samples. The 
role of miRNAs in other neurological disorders has been reviewed (Xu, Karayiorgou & 
Gogos 2010). 
3. Methods of oligodendrocyte differentiation 
Unlike animal models, the study of oligodendrocyte development in humans has been 
generally limited in scope by the lack of models both in vivo and vitro that can be utilized to 
study this process. However, human embryonic stem cells provide an exciting model to help 
identify mechanisms that regulate the differentiation of oligodendrocytes. This includes 
elucidating the role of miRNAs in regulating the oligodendrocyte fate. This section describes 
a novel protocol for generating oligodendrocyte fated cells from human embryonic stem 
cells which have been developed in part from several published protocols (Nistor et al. 2005, 
Kerr et al. 2010). 
3.1 Materials 
3.1.1 Buffers and solutions 
PBS: Phosphate buffered saline, without Ca+2 and Mg+2, pH 7.0 (Invitrogen). 
Trypsin/EDTA: HBSS containing 0.05% trypsin and 0.53 mM EDTA (Sigma). 
Collagenase: 1mg/ ml collagenase IV (Invitrogen) in PBS, filtered. 
3.1.2 Culture media 
Basic culture medium for MEF: (Mouse embryonic fibroblast line PMEF-CF1 from 
Millipore): DMEM high glucose, supplemented with 10% Fetal Bovine Serum (Invitrogen), 2 
mM glutamax (Invitrogen), 5 U/ml penicillin–streptomycin (Invitrogen), and 0.1 mM non-
essential amino acids (NEAA). 
Basic culture medium for undifferentiated human embryonic stem cells: DMEM/F12 
(Invitrogen), supplemented with 20% Knockout Serum Replacement (Invitrogen), 2 mM 
glutamax (Invitrogen), 5 U/ml penicillin–streptomycin (Invitrogen), 0.1 mM non-essential 
amino acids and 3.5 µl ǃ-mercaptoethanol supplemented with basic fibroblast growth factor 
(FGF2). 
Basic culture medium for neural and oligodendrocyte progenitors: Neural Basal Media, 
supplemented with 10% Bovine Serum Albumin in PBS, filtered (Gibco), 0.5% N2 
supplement (Invitrogen), 0.1 mM ǃ-mercaptoethanol (Sigma) and 25 ug/ml gentamicin 
(Invitrogen). 
3.1.3 Fixatives 
4% Paraformaldehyde: 4g paraformaldehyde in 100 ml PBS. To dissolve the 
paraformaldehyde, the PBS was preheated at 90°C and sodium hydroxide (NaOH) added 
drop-wise slowly until the solution turns clear. The solution was cooled down before use.  
3.2 Cell culture 
Human ESCs were maintained on irradiated mouse embryonic fibroblasts (MEFs) in ESC 
growth media. Prior to differentiation, ESCs were separated from the feeder layer using a 
www.intechopen.com
 Oligodendrocyte Fate Determination in Human Embryonic Stem Cells 
 
125 
solution of 1 mg/ml collagenase and plated on a 4% matrigel (BD Biosciences) substrate for 
5 to 7 days and fed feeder-conditioned media daily. Cells were subsequently differentiated 
into embryoid bodies (EBs), neural progenitors (NPC), glial restricted precursors (GPC), 
and oligodendrocyte precursors (OPC) and finally mature oligodendrocytes (OL). 
3.2.1 Preparation of MEF feeder layers 
MEFs were maintained in basic MEF culture medium. The feeder cells were prepared the 
day before ESCs are expanded.  The MEFs were plated at a density of 10 x 104 cells/cm2 onto 
0.1% w/v gelatin (Stem Cell Technologies) -coated culture dishes. Next morning, the feeder 
plates were Ǆ-irradiated with a dose of 50 Gy (5000 rads) to induce cell cycle arrest. After 
irradiation, the culture medium was replaced. MEFs can also be mitotically-inactivated by 
treatment with mitomycin C (Sigma) at a concentration of 10 µg/ml for 4 hours at 37ºC. The 
ESCs were plated on top of the MEF feeder layer using collagenase as described below. The 
medium was replaced daily with fresh medium supplemented with growth factors. 
3.2.2 Human embryonic stem cells 
The derivation and maintenance of human embryonic stem cells has been covered at length 
and details can be found in the following reviews (Park et al. 2003, Draper et al. 2004, Lu et 
al. 2006, Suemori et al. 2006, Ludwig et al. 2006, Hoffman, and Carpenter 2005). In brief, a 
culture plate with mitotically inactivated MEF feeder cells was prepared 24 h before use 
with ESCs with MEF basic culture media. The medium was removed from a culture dish of 
ESCs and the dish was washed with PBS. ESC can be expanded using either collagenase or 
trypsin. In both cases, however, over trypsinization of the colonies should be avoided 
because it will reduce cell viability. This could occur by incubating cells too long with 
enzyme and/or over triturating. For one 10 cm plate of ESCs, 1 ml of collagenase or trypsin 
solution was added and placed in incubator at 37ºC for 5 to 10 min. The plate was removed 
from the incubator, the bottom of the plate scraped with a 5 ml pipette, making sure that all 
colonies had been lifted off, and then triturated slowly until only very small clumps were 
obtained. The colonies were not broken up into single cells as unlike their mouse 
counterparts, human ESCs do not survive well as single cells. The  cell suspension was 
transferred into a 15 ml conical tube, 10 ml complete medium added and centrifuged for 5 to 
10 min at 200 g at room temperature (RT). The pellet was resuspended in complete medium 
and placed onto mitotically-inactivated MEF feeder cell plate containing ESC complete 
medium with FGF2. The medium was replaced daily until ESC colonies reached optimal 
size for further passage. ESCs usually expanded by 5 fold after 5-7 days. 
3.2.3 Embryoid body formation 
Neural differentiation of ESCs was initiated via embryoid body (EB) suspensions. 
Embryonic stem cells were plated and dissociated onto 10 cm matrigel-coated tissue culture 
dishes as described above for passaging ESCs onto 10 cm plates with MEF. When ESCs were 
transferred onto matrigel they were grown in basic ESC culture media that had been 
conditioned on MEFs (live or irradiated) for 24 hours (12 ml of media per 10cm of confluent 
feeders), filtered and supplemented with 4 ng/ml FGF2. MEF-conditioned media was 
replaced on a daily basis until colonies were large and tight, almost near confluency in the 
wells.  
To generate embryoid bodies, the medium was removed from a culture dish of ESCs and 
the dish washed with PBS. For one six well plate of ESCs, the cells were incubated in 0.5 ml 
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of 1 mg/ml collagenase in PBS (avoid trypsinization as it can affect cell viability) and placed 
into the incubator at 37ºC for 5 to 10 min. After removing the tube from the incubator, the 
cells were scraped with a cell scraper or lifter. The cell suspension was transferred to a 
centrifuge tube very gently, 10 ml of neural basal media supplemented with 200 ng/ml 
noggin, 20 ng/ml FGF2, and 20 ng/ml FGF4 (all growth factors from R&D Systems) was 
added and centrifuged for 5 min at 200 g, (RT). The supernatant was removed and the pellet 
gently resuspended into complete medium and placed onto a non-adherent or low adhesive 
10 cm culture plate (Corning).  
Neural EBs were fed daily by sedimentation. This was performed by tilting the dish at a 45 
degree angle, waiting 5 minutes, and carefully aspirating with a 5ml pipette only half of the 
media so as to not discard the EBs floating in suspensions. EBs were grown for 10-25 days 
until they produced a transparent morphology. EBs were characterized by their loss of 
pluripotent markers, AP, OCT4, and NANOG and initiation of early markers of 
neuroectodermal fate including SSEA1, SOX1, PAX6 and Islet1 (Figure 1). The time may 
vary for different cell lines to reach this stage. Thus, the time at which is takes EBs to express 
these markers is dependent on the ESC line employed and so the cells should always be 
characterized at this point before proceeding forward. This can be performed by RT-PCR 
and by immunohistochemistry by freezing EBs in cryoprotectant mount media such as 
O.C.T. (Sakura Finetek TissueTek) and antibody staining (Table 1). The timeline provided 
here is based on our experiences using ESC lines H1 and H9 generated by Thomson et al 
(Thomson et al. 1998). 
 
 
Fig. 1. Timeline of oligodendrocyte differentiation from pluripotent human embryonic stem 
cells, showing the expression of relevant cellular markers at each stage. 
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Fig. 2. Phase contrast images of various stages of oligodendrocyte differentiation. 
A. Pluripotent human embryonic stem cells on MEFs, B. EBs one day after being generated 
by the scraping method, C. NPCs sprouting from the periphery of a plated EB on matrigel 
after 24 hrs, D. OPC 9 days after 2 expansions in OPC inducing medium, and OLs one week 
after being exposed to OL inducing media. 
3.2.4 Neural progenitor cells 
10 cm tissue culture plates were coated with 3 ml of 4% matrigel in neural basal media for 
one hour prior to plating EBs. Human ESC Qualified Matrigel Matrix was thawed overnight 
at 4°C then diluted 1:24 (approximately 4% Matrigel) in cold neural basal medium.  
Afterwards, the matrigel was removed and EBs plated in 10 ml of neural basal media 
supplemented with 20 ng/ml FGF2 for 5 to 10 days. In this time, EBs spread over the plate 
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and became confluent. Most cells expressed neural fated markers including nestin and 
neural surface marker (A2B5) (Figure 1). NPCs at this stage were capable of deriving cells 
with both neuronal and glial fates. NPCs were fed daily. 
3.2.5 Glial progenitor cells 
NPCs were passaged in 1 to 3 splits for expansion using collagenase as described below 
(Passaging Cells) and replated on matrigel coated plates for differentiation into glial 
progenitor fate. Twenty-four hours after replating, media was changed to neural basal 
media supplemented with 20ng/ml EGF. Cells were fed daily for 10-14 days. GPCs began to 
express NG2, PDGFRǂ, and Olig1 (Figure 1). These cells can differentiate into either 
astrocytes or oligodendrocytes at this stage depending on the growth factors employed.  
3.2.6 Oligodendrocyte progenitor cells 
To promote differentiation into OPC, the media was supplemented with 20 ng/ml PDGF-
AA.  Cells were fed daily and begin to express OPC markers O1, O4, CNP, RIP, and GalC 
after one week (Figure 1). After 7–10 days the OPC morphology could be detected and was 
visible on the culture dish (Figure 2). By two weeks greater than 95% pure OPC could be 
obtained. Pure populations of OPCs can be obtained by FACs or MACs using O1 and O4 
antibody selection using standard procedures. Once an OPC line is derived, cells can be 
expanded using 1 mg/ml collagenase in PBS onto gelatin-coated plates for several months 
before they reach senescence. 
3.2.7 Oligodendrocytes 
Terminal differentiation to mature oligodendrocytes was initiated by the addition of 50 
ng/ml T3 (triiodothyronine, Sigma) and removal of PDGF-AA from the neural basal 
medium. Mature OLs demonstrate complex morphology after 3-5 days and express myelin-
associated proteins such as MAG, MOG, MOBP, and MBP (Figure 1). These cells do not 
survive as long as the progenitor cells and begin to die off after the first week. In total, their 
survival under these culture conditions is between 1-3 weeks after maturity.  
3.2.8 Passaging cells  
3 ml of 0.1% matrigel is placed on a 10cm tissue culture plate. The medium is removed from 
a culture dish of OL-fated cells and the dish washed with PBS. For one six well plate, the 
cells were incubated in 0.5 ml of 1 mg/ml collagenase in PBS (avoid trypsinization as it can 
affect cell viability) and cells placed into the incubator at 37ºC for 5 to 10 min. After 
removing the tube from the incubator, the cells were scraped with cell scraper or lifter. The 
suspension was mixed by gently pipetting up and down the cell clumps until a single-cell 
suspension was obtained. Importantly, to reduce cell mortality, the extent of cell disruption 
was controlled by pipetting only 5 to 10 times and with a 5ml pipette. The cell suspension 
was transferred to a centrifuge tube and centrifuge for 5 min at 200g at RT. The supernatant 
was removed and pellet resuspended in complete medium and placed onto the matrigel-
coated plates. Medium was replaced daily until the cells were confluent before passaging 
onto a larger culture dish plate. 
3.2.9 Freezing cells 
From one confluent 6-well ESCs, NPCs, GPCs or OPCs were dissociated using collagenase 
as described above. These were rinsed in neural basal media for neural cells and ESC media 
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for ESCs at 200g for 5 min. The supernatant was aspirated and the pellet resuspended in 
freshly prepared 1X Freezing Media (for neural cells: 50% Neural Basal Media, 40% FCS, 
10% DMSO; ESC freezing media: 50% Fetal Bovine Serum (Defined, Hyclone), 40% Neural 
Basal Media (Invitrogen) and 10% DMSO (Sigma), filtered).  1 ml of freezing media was 
added dropwise, mixing well after each addition. The suspension was transferred into 
sterile freezing vials, and placed into cryovessels. The cells were frozen overnight at -80oC, 
and then transferred to the liquid nitrogen freezer after 24 hours. 
3.2.10 Thawing out cells 
The vial of frozen cells was removed from the nitrogen freezer and transferred to a 37oC 
heat water bath to thaw by gentle shaking (thawing generally takes only 1-2 minutes). The 
suspension was transferred into 15 cc conical tube and 10 ml of culture media added and 
centrifuged at 200g for 5 min. The supernatant was removed, culture medium added, and 
plated directly onto a fresh matrigel coated plate for NPs, GPCs and OPCs or feeder plate 
for ESCs. 
 
Name Company Product Code 
Oct-4 BD Biosciences 611203 
Nanog EBioscience 14-5768-82 
Sox-2 Abcam ab15830-100 
Sox-1 Abcam ab22572 
Pax-6 Abcam ab5790 
Nestin Millipore mab5326 
Islet-1 DSHB 394D5 
A2B5 Millipore mab312r 
Sox-10 Santa Cruz Bio. sc17343 
Olig1 Millipore mab5540 
PDGFR-a Abcam ab61219 
NG2 Millipore ab5320 
O4 Millipore mab345 
O1 Millipore mab344 
RIP Abcam ab2035 
CNPase Millipore mab326r 
MBP Abcam ab7349-2 
Table 1. Specific antibodies for oligodendrocyte characterization 
3.3 Cell characterization 
The identity of a cell in the differentiation pathway from pluripotent embryonic stem cells to 
mature oligodendrocytes is most commonly studied by its morphology, its gene expression 
and by analyzing the expression of protein markers by immunodetection.  
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Morphologically, undifferentiated ESCs generate colonies on top of feeders, NPC are more 
columnar or cuboidal in shape while GPCs and OPCs generate bipolar cells. Mature OLs 
demonstrate a complex network of dendritic processes (Figure 2). 
Immunofluorescence (IF) staining of plated cells is more accurate morphology and the 
simplest method of analyzing protein expression to define the different stages of OL 
potential (Table 1 lists sources of reliable antibodies for OL characterization). Here we 
present a standard protocol for IF staining for OL fated cells. Figure 3 demonstrates staining 
at various stages of OL differentiation. 
Cells were plated onto 24-well culture plates. Before cells became confluent, cells were 
washed twice in PBS and the excess PBS was removed. Cells were fixed in 4% PFA in PBS 
for 10 minutes at RT. The fixative solution was removed and wells washed twice with PBS 
for 5 min each. Cells were permeabilized and blocked with PBS solution containing 0.2% 
(w/v) Triton X-100 and bovine serum albumin (BSA; Sigma) at a concentration 1% (w/v) in 
PBS and incubated for 5 minutes at RT (for cells surface markers this step was skipped). 
Primary antibody (1:50 dilution) was added after dilution in antibody dilution buffer (PBS 
with 0.1% (w/v) BSA) and incubated for 1 hr at RT. Sample was washed three times with 
PBS for 5 minutes each. Appropriate secondary antibody was added (Alexa488 or Alexa546 
conjugated antibodies, 1:200; Molecular Probes) in antibody dilution buffer and incubated in 
a humidified dark chamber for 1 hr at RT. Washed three times with PBS for 5 min each. 
Nuclei were stained with DAPI solution (Sigma) for 10 min at RT in a humidified chamber 
in the dark. DAPI solution was aspirated and 0.5 ml PBS was added to each well. Samples 
were examined under a fluorescence microscope with appropriate filters within 24 hrs as 
signal diminishes very rapidly. After 2 to 3 days most of the fluorescence signal is bleached. 
Sealant tape and aluminum foil was applied around the plates and stored in the dark at 4ºC 
(short term storage only). 
4. Results 
4.1 Morphological analysis of differentiated cells 
As shown in Figure 2, oligodendrocytes were successfully differentiated from human 
embryonic stem cells by our protocol described above. Embryoid bodies (Fig. 2b) were 
generated from pluripotent embryonic stem cells colonies (Fig. 2a). Plating these embryoid 
bodies on matrigel led to their adhesion and appearance of neural progenitor cells (Fig. 2c), 
which were then differentiated to glial progenitors (Fig. 2d) and subsequently 
oligodendrocyte progenitor cells (Fig 2e). Removal of all growth factors from the media led 
to the appearance of mature oligodendrocytes (Fig. 2e).  
4.2 Immunocytochemistry of differentiated cells 
EBs were characterized by their loss of pluripotent markers, AP, OCT4, and NANOG and 
initiation of early markers of neuroectodermal fate including SSEA1, SOX1, PAX6 and Islet1 
(Figure 1). Upon contact with matrigel, EBs spread over the plate and became confluent. 
Most cells expressed neural fated markers including nestin and neural surface marker 
(A2B5)(Figure 1). After 5-7 days in NP media and addition of EGF, GPCs appeared and 
began to express NG2, PDGFRǂ, and Olig1 (Figure 1). Subsequent addition of PDGF-AA 
after 7 days led to the appearance of OPC markers O1, O4, CNP, RIP, and GalC (Figure 1). 
Finally, mature oligodendrocytes express myelin-associated proteins such as MAG, MOG, 
MOBP, and MBP (Figure 1). 
www.intechopen.com
 Oligodendrocyte Fate Determination in Human Embryonic Stem Cells 
 
131 





Fig. 3. Indirect immunofluorescence microscopy to examine differentiation of human ESCs 
into the oligodendrocyte lineage. The nuclei are stained blue by DAPI. Nestin (green) is 
shown for neural progenitors while NG2 (red), PDGFRa (green) O4 (red), RIP (red) and 
NOGO-a (green) are expressed by 5-day old oligodendrocyte progenitor cells.  
5. Conclusion 
In conclusion, a novel protocol adapted from previously published ones for oligodendrocyte 
development from pluripotent human embryonic stem cells has been developed. The cells 
express the established neural, glial and oligodendroglial markers as they advance along the 
differentiation timeline and we have confirmed this using indirect immunofluorescent 
microscopy.  
Also, we have reviewed the current state of knowledge about microRNA regulation of 
oligodendrocyte differentiation from pluripotent cells and myelination of CNS neurons by 
those cells. It is hoped that the protocol for obtaining OLs in high purity will aid in the 
unraveling of more mechanisms of miRNA regulation of myelination so that this knowledge 
can eventually be used for the development of a more efficient approach to the stem cell 
based therapy of spinal cord injuries and other demyelinating disorders.  
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